JAB1 is essential for B cell development and germinal center formation and inversely regulates fas ligand and Bcl6 expression

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2677-2686

  Sitte, Selina ^a   Gläsner, Joachim ^b   Jellusova, Julia ^c   Weisel, Florian ^d   Panattoni, Martina ^e   Pardi, Ruggero ^e   Gessner, André ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; PROTEIN BCL 6; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL FATE; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; GENE DELETION; GENE OVEREXPRESSION; GENE REPRESSION; GERMINAL CENTER; IMMUNE RESPONSE; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GERMINAL CENTER; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE HYDROLASES; PRECURSOR CELLS, B-LYMPHOID; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84857806053     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101455     Document Type: Article

References (44)

1. Claret, F.-X., M. Hibi, S. Dhut, T. Toda, and M. Karin. 1996. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383: 453-457. (Pubitemid 26330837)
2. Seeger, M., R. Kraft, K. Ferrell, D. Bech-Otschir, R. Dumdey, R. Schade, C. Gordon, M. Naumann, and W. Dubiel. 1998. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J. 12: 469-478. (Pubitemid 28146526)
3. Wei, N., T. Tsuge, G. Serino, N. Dohmae, K. Takio, M. Matsui, and X.-W. Deng. 1998. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol. 8: 919-922. (Pubitemid 28371757)
4. Wei, N., G. Serino, and X.-W. Deng. 2008. The COP9 signalosome: more than a protease. Trends Biochem. Sci. 33: 592-600.
5. Cope, G. A., G. S. B. Suh, L. Aravind, S. E. Schwarz, S. L. Zipursky, E. V. Koonin, and R. J. Deshaies. 2002. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 298: 608-611. (Pubitemid 35215316)
6. Oron, E., M. Mannervik, S. Rencus, O. Harari-Steinberg, S. Neuman-Silberberg, D. Segal, and D. A. Chamovitz. 2002. COP9 signalosome subunits 4 and 5 regulate multiple pleiotropic pathways in Drosophila melanogaster. Development 129: 4399-4409. (Pubitemid 35203724)
7. Rosel, D., and A. R. Kimmel. 2006. The COP9 signalosome regulates cell proliferation of Dictyostelium discoideum. Eur. J. Cell Biol. 85: 1023-1034. (Pubitemid 44317597)
8. Tomoda, K., N. Yoneda-Kato, A. Fukumoto, S. Yamanaka, and J. Y. Kato. 2004. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J. Biol. Chem. 279: 43013-43018. (Pubitemid 39372195)
9. Panattoni,M.,F. Sanvito, V.Basso, C. Doglioni, G. Casorati, E.Montini, J. R. Bender, A. Mondino, and R. Pardi. 2008. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J. Exp. Med. 205: 465-477. (Pubitemid 351281610)
10. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448.
11. Strasser, A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
12. Herzog, S., M. Reth, and H. Jumaa. 2009. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat. Rev. Immunol. 9: 195-205.
13. Lu, L., and D. G. Osmond. 2000. Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow. Immunol. Rev. 175: 158-174. (Pubitemid 30427166)
14. MacLennan, I. C. M. 1994. Germinal centers. Annu. Rev. Immunol. 12: 117-139. (Pubitemid 24140411)
15. Dent, A. L., A. L. Shaffer, X. Yu, D. Allman, and L. M. Staudt. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276: 589-592. (Pubitemid 27193682)
16. Fukuda, T., T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, et al. 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186: 439-448. (Pubitemid 27332902)
17. Ye, B. H., G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R. S. Chaganti, et al. 1997. The BCL-6 protooncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16: 161-170.
18. Ranuncolo, S. M., J. M. Polo, J. Dierov, M. Singer, T. Kuo, J. Greally, R. Green, M. Carroll, and A. Melnick. 2007. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNAdamage sensor ATR. Nat. Immunol. 8: 705-714. (Pubitemid 46965346)
19. Allman,D.,A. Jain, A. Dent,R. R.Maile,T. Selvaggi,M.R. Kehry, andL.M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood 87: 5257-5268. (Pubitemid 26189869)
20. MacLennan, I. C. M., K.-M. Toellner, A. F. Cunningham, K. Serre, D. M.-Y. Sze, E. Zúñiga, M. C. Cook, and C. G. Vinuesa. 2003. Extrafollicular antibody responses. Immunol. Rev. 194: 8-18. (Pubitemid 36886424)
21. McKisic, M. D.,W. L. Redmond, and S. W. Barthold. 2000. Cutting edge: T cellmediated pathology in murine Lyme borreliosis. J. Immunol. 164: 6096-6099. (Pubitemid 30408784)
22. Yang, L., Y. Ma, R. Schoenfeld, M. Griffiths, E. Eichwald, B. Araneo, and J. J. Weis. 1992. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60: 3033-3041.
23. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139: 263-273.
24. Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162: 133-138. (Pubitemid 20223961)
25. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P. J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103: 13789-13794. (Pubitemid 44413986)
26. Strasser, A., S. Whittingham, D. L. Vaux, M. L. Bath, J. M. Adams, S. Cory, and A. W. Harris. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88: 8661-8665. (Pubitemid 21915417)
27. Gläsner, J., H. Blum, V. Wehner, H. U. Stilz, J. D. Humphries, G. P. Curley, A. P. Mould, M. J. Humphries, R. Hallmann, M. Röllinghoff, and A. Gessner. 2005. A small molecule alpha 4 beta 1 antagonist prevents development of murine Lyme arthritis without affecting protective immunity. J. Immunol. 175: 4724-4734. (Pubitemid 41362014)
28. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213-1225.
29. Fukazawa, T., T. Fujiwara, Y. Morimoto, J. Shao, M. Nishizaki, Y. Kadowaki, A. Hizuta, L. B. Owen-Schaub, J. A. Roth, and N. Tanaka. 1999. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Oncogene 18: 2189-2199. (Pubitemid 29186920)
30. Vaux, D. L., S. Cory, and J. M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
31. Cory, S., and J. M. Adams. 2002. The Bcl2 family: regulators of the cellular life-or- death switch. Nat. Rev. Cancer 2: 647-656. (Pubitemid 37328916)
32. Brunner, C., D. Marinkovic, J. Klein, T. Samardzic, L. Nitschke, and T. Wirth. 2003. B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice. J. Exp. Med. 197: 1205-1211. (Pubitemid 36570076)
33. Crowley, M. T., C. R. Reilly, and D. Lo. 1999. Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. J. Immunol. 163: 4894-4900. (Pubitemid 29501254)
34. Goetz, C. A., I. R. Harmon, J. J. O'Neil, M. A. Burchill, and M. A. Farrar. 2004. STAT5 activation underlies IL7 receptor-dependent B cell development. J. Immunol. 172: 4770-4778. (Pubitemid 38456398)
35. Smith, K. G. C., U. Weiss, K. Rajewsky, G. J. V. Nossal, and D. M. Tarlinton. 1994. Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers. Immunity 1: 803-813.
36. Muramatsu, M., V. S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, N. O. Davidson, and T. Honjo. 1999. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274: 18470-18476.
37. Cattoretti, G., C.-C. Chang, K. Cechova, J. Zhang, B. H. Ye, B. Falini, D. C. Louie, K. Offit, R. S. K. Chaganti, and R. Dalla-Favera. 1995. BCL-6 protein is expressed in germinal-center B cells. Blood 86: 45-53.
38. Fukumoto, A., K. Tomoda, N. Yoneda-Kato, Y. Nakajima, and J. Y. Kato. 2006. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines. FEBS Lett. 580: 5836-5844. (Pubitemid 44584281)
39. Yoshida, A., N. Yoneda-Kato, M. Panattoni, R. Pardi, and J. Y. Kato. 2010. CSN5/Jab1 controls multiple events in the mammalian cell cycle. FEBS Lett. 584: 4545-4552.
40. Voss, M., M. Lettau, M. Paulsen, and O. Janssen. 2008. Posttranslational regulation of Fas ligand function. Cell Commun. Signal. 6: 11.
41. Kirkin, V., N. Cahuzac, F. Guardiola-Serrano, S. Huault, K. Lückerath, E. Friedmann, N. Novac, W. S. Wels, B. Martoglio, A. O. Hueber, and M. Zörnig. 2007. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differ. 14: 1678-1687. (Pubitemid 47278853)
42. Lückerath, K., V. Kirkin, I. M. Melzer, F. B. Thalheimer, D. Siele, W. Milani, T. Adler, A. Aguilar-Pimentel, M. Horsch, G. Michel, et al. 2011. Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain. Blood 117: 519-529.
43. Nagasawa, T. 2006. Microenvironmental niches in the bone marrow required for B-cell development. Nat. Rev. Immunol. 6: 107-116. (Pubitemid 43361586)
44. Duy, C., J. J. Yu, R. Nahar, S. Swaminathan, S.-M. Kweon, J. M. Polo, E. Valls, L. Klemm, S. Shojaee, L. Cerchietti, et al. 2010. BCL6 is critical for the development of a diverse primary B cell repertoire. J. Exp. Med. 207: 1209-1221.